Target Validation Information | |||||
---|---|---|---|---|---|
Target ID | T30687 | ||||
Target Name | mRNA of glucocorticoid receptor | ||||
Target Type | Clinical Trial |
||||
Drug Potency against Target | CP-394531 | Drug Info | Ki = 0.1 nM | [530804] | |
A-348441 | Drug Info | IC50 = 1.2 nM | [528441] | ||
EPIERENONE | Drug Info | Ki = 1758 nM | [529171] | ||
AL-43 | Drug Info | IC50 = 13 nM | [527002] | ||
LGD-5552 | Drug Info | Ki = 2.4 nM | [529166] | ||
4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one | Drug Info | Ki < 1000 nM | [531079] | ||
OXDEX | Drug Info | IC50 = 600 nM | [530264] | ||
ONAPRISTONE | Drug Info | IC50 = 27 nM | [526633] | ||
LG-120838 | Drug Info | IC50 = 1050 nM | [534728] | ||
1-(3-CHLORO-4-FLUOROPHENYL)-2,2,2-TRIFLUORO-1-(1-(4-FLUOROPHENYL)-1H-INDAZOL-5-YL)ETHANOL (ENANTIOMERIC MIX) | Drug Info | IC50 = 49 nM | [530879] | ||
2,2,2-TRIFLUORO-1-(4-FLUOROPHENYL)-1-(1-(4-FLUOROPHENYL)-1H-INDAZOL-5-YL)ETHANOL (DIASTEREOMERIC MIX) | Drug Info | IC50 = 161 nM | [530879] | ||
1-(2,3-DICHLOROPHENYL)-2,2,2-TRIFLUORO-1-(1-(4-FLUOROPHENYL)-1H-INDAZOL-5-YL)ETHANOL (ENANTIOMERIC MIX) | Drug Info | IC50 = 34 nM | [530879] | ||
1-Methoxy-6-phenyl-6H-benzo[c]chromene | Drug Info | IC50 = 10000 nM | [527034] | ||
RU-43044 | Drug Info | Ki = 0.1 nM | [530804] | ||
CP-409069 | Drug Info | Ki = 0.17 nM | [530804] | ||
1-Methoxy-6-phenyl-6H-benzo[c]chromen-8-ylamine | Drug Info | IC50 = 1937 nM | [527034] | ||
ENDIANDRIN A | Drug Info | IC50 = 900 nM | [528911] | ||
WAY-252623 | Drug Info | IC50 = 1000 nM | [529781] | ||
DI-O-METHYLENDIANDRIN A | Drug Info | IC50 = 13000 nM | [528911] | ||
WAY-214950 | Drug Info | IC50 = 7200 nM | [529781] | ||
References | |||||
Ref 530804 | J Med Chem. 2010 Apr 22;53(8):3065-74.Virtual screening for the identification of novel nonsteroidal glucocorticoid modulators. | ||||
Ref 528441 | Bioorg Med Chem Lett. 2006 Dec 1;16(23):6086-90. Epub 2006 Sep 20.Synthesis and activity of novel bile-acid conjugated glucocorticoid receptor antagonists. | ||||
Ref 529171 | J Med Chem. 2007 Dec 27;50(26):6443-5. Epub 2007 Nov 27.(S)-N-{3-[1-cyclopropyl-1-(2,4-difluoro-phenyl)-ethyl]-1H-indol-7-yl}-methanesulfonamide: a potent, nonsteroidal, functional antagonist of themineralocorticoid receptor. | ||||
Ref 527002 | Bioorg Med Chem Lett. 2004 Apr 5;14(7):1721-7.Differentiation of in vitro transcriptional repression and activation profiles of selective glucocorticoid modulators. | ||||
Ref 529166 | Proc Natl Acad Sci U S A. 2007 Dec 4;104(49):19244-9. Epub 2007 Nov 21.Antiinflammatory glucocorticoid receptor ligand with reduced side effects exhibits an altered protein-protein interaction profile. | ||||
Ref 531079 | J Med Chem. 2010 Sep 9;53(17):6386-97.Discovery of N-{1-[3-(3-oxo-2,3-dihydrobenzo[1,4]oxazin-4-yl)propyl]piperidin-4-yl}-2-phenylacetamide (Lu AE51090): an allosteric muscarinic M1 receptor agonist with unprecedented selectivity and procognitive potential. | ||||
Ref 530264 | J Med Chem. 2009 Aug 13;52(15):4604-12.Investigation of the relative cellular permeability of DNA-binding pyrrole-imidazole polyamides. | ||||
Ref 526633 | Bioorg Med Chem Lett. 2003 Jun 16;13(12):2075-8.Development of progesterone receptor antagonists from 1,2-dihydrochromeno[3,4-f]quinoline agonist pharmacophore. | ||||
Ref 534728 | J Med Chem. 1998 Oct 22;41(22):4354-9.5-Benzylidene 1,2-dihydrochromeno[3,4-f]quinolines, a novel class of nonsteroidal human progesterone receptor agonists. | ||||
Ref 530879 | Bioorg Med Chem Lett. 2010 May 15;20(10):3017-20. Epub 2010 Apr 11.5-Functionalized indazoles as glucocorticoid receptor agonists. | ||||
Ref 530879 | Bioorg Med Chem Lett. 2010 May 15;20(10):3017-20. Epub 2010 Apr 11.5-Functionalized indazoles as glucocorticoid receptor agonists. | ||||
Ref 530879 | Bioorg Med Chem Lett. 2010 May 15;20(10):3017-20. Epub 2010 Apr 11.5-Functionalized indazoles as glucocorticoid receptor agonists. | ||||
Ref 527034 | Bioorg Med Chem Lett. 2004 May 3;14(9):2079-82.Synthesis and biological evaluation of novel, selective, nonsteroidal glucocorticoid receptor antagonists. | ||||
Ref 530804 | J Med Chem. 2010 Apr 22;53(8):3065-74.Virtual screening for the identification of novel nonsteroidal glucocorticoid modulators. | ||||
Ref 530804 | J Med Chem. 2010 Apr 22;53(8):3065-74.Virtual screening for the identification of novel nonsteroidal glucocorticoid modulators. | ||||
Ref 527034 | Bioorg Med Chem Lett. 2004 May 3;14(9):2079-82.Synthesis and biological evaluation of novel, selective, nonsteroidal glucocorticoid receptor antagonists. | ||||
Ref 528911 | J Nat Prod. 2007 Jul;70(7):1118-21. Epub 2007 Jun 21.Endiandrin A, a potent glucocorticoid receptor binder isolated from the Australian plant Endiandra anthropophagorum. | ||||
Ref 529781 | J Med Chem. 2008 Nov 27;51(22):7161-8.Indazole-based liver X receptor (LXR) modulators with maintained atherosclerotic lesion reduction activity but diminished stimulation of hepatic triglyceride synthesis. | ||||
Ref 528911 | J Nat Prod. 2007 Jul;70(7):1118-21. Epub 2007 Jun 21.Endiandrin A, a potent glucocorticoid receptor binder isolated from the Australian plant Endiandra anthropophagorum. | ||||
Ref 529781 | J Med Chem. 2008 Nov 27;51(22):7161-8.Indazole-based liver X receptor (LXR) modulators with maintained atherosclerotic lesion reduction activity but diminished stimulation of hepatic triglyceride synthesis. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.